UK smallpox vaccine comes under fire from USBMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7359.298/c (Published 10 August 2002) Cite this as: BMJ 2002;325:298
- Owen Dyer
New American research has sparked controversy by claiming that the British government may have bought an ineffective smallpox vaccine to counter bioterrorist attack. The interim results of a study by the Potomac Institute for Policy Studies, in Arlington, Virginia, suggest that the 20 million doses of Lister vaccine recently ordered by Britain are less protective against viral strains likely to be used by terrorists than the vaccine bought by the US government.
The research by the Potomac Institute's National Security Health Policy Center looked at smallpox eradication campaigns as far back as 1860 and concluded that the greatest success came with vaccines based on …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial